The global mHealth market size is calculated at USD 81.71 billion in 2025 and is projected to surpass around USD 268.46 billion by 2034, expanding at a CAGR of 14.13% from 2025 to 2034. The North America mHealth market size reached at USD 27.10 billion in 2024 and is expanding at a CAGR of 14.15% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: mHealth Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. mHealth Market, by Component Type,
8.1.1. Apps (Medical Apps, Fitness Apps)
8.1.1.1. Market Revenue and Forecast
8.1.2. Wearables (Glucose Meters, Pulse Oximeters, Sleep Apnea Monitors (PSG), Neurological Monitors, Activity Trackers/ Actigraphs)
8.1.2.1. Market Revenue and Forecast
9.1. mHealth Market, by Application,
9.1.1. Diagnosis
9.1.1.1. Market Revenue and Forecast
9.1.2. Monitoring
9.1.2.1. Market Revenue and Forecast
9.1.3. Treatment
9.1.3.1. Market Revenue and Forecast
10.1. mHealth Market, by Participants,
10.1.1. Mobile Operators
10.1.1.1. Market Revenue and Forecast
10.1.2. Device Vendors
10.1.2.1. Market Revenue and Forecast
10.1.3. Content Players
10.1.3.1. Market Revenue and Forecast
10.1.4. Healthcare Providers
10.1.4.1. Market Revenue and Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Component
11.1.2. Market Revenue and Forecast, by Application
11.1.3. Market Revenue and Forecast, by Participants
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Component
11.1.4.2. Market Revenue and Forecast, by Application
11.1.4.3. Market Revenue and Forecast, by Participants
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Component
11.1.5.2. Market Revenue and Forecast, by Application
11.1.5.3. Market Revenue and Forecast, by Participants
11.2. Europe
11.2.1. Market Revenue and Forecast, by Component
11.2.2. Market Revenue and Forecast, by Application
11.2.3. Market Revenue and Forecast, by Participants
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Component
11.2.4.2. Market Revenue and Forecast, by Application
11.2.4.3. Market Revenue and Forecast, by Participants
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Component
11.2.5.2. Market Revenue and Forecast, by Application
11.2.5.3. Market Revenue and Forecast, by Participants
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Component
11.2.6.2. Market Revenue and Forecast, by Application
11.2.6.3. Market Revenue and Forecast, by Participants
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Component
11.2.7.2. Market Revenue and Forecast, by Application
11.2.7.3. Market Revenue and Forecast, by Participants
11.3. APAC
11.3.1. Market Revenue and Forecast, by Component
11.3.2. Market Revenue and Forecast, by Application
11.3.3. Market Revenue and Forecast, by Participants
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Component
11.3.4.2. Market Revenue and Forecast, by Application
11.3.4.3. Market Revenue and Forecast, by Participants
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Component
11.3.5.2. Market Revenue and Forecast, by Application
11.3.5.3. Market Revenue and Forecast, by Participants
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Component
11.3.6.2. Market Revenue and Forecast, by Application
11.3.6.3. Market Revenue and Forecast, by Participants
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Component
11.3.7.2. Market Revenue and Forecast, by Application
11.3.7.3. Market Revenue and Forecast, by Participants
11.4. MEA
11.4.1. Market Revenue and Forecast, by Component
11.4.2. Market Revenue and Forecast, by Application
11.4.3. Market Revenue and Forecast, by Participants
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Component
11.4.4.2. Market Revenue and Forecast, by Application
11.4.4.3. Market Revenue and Forecast, by Participants
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Component
11.4.5.2. Market Revenue and Forecast, by Application
11.4.5.3. Market Revenue and Forecast, by Participants
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Component
11.4.6.2. Market Revenue and Forecast, by Application
11.4.6.3. Market Revenue and Forecast, by Participants
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Component
11.4.7.2. Market Revenue and Forecast, by Application
11.4.7.3. Market Revenue and Forecast, by Participants
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Component
11.5.2. Market Revenue and Forecast, by Application
11.5.3. Market Revenue and Forecast, by Participants
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Component
11.5.4.2. Market Revenue and Forecast, by Application
11.5.4.3. Market Revenue and Forecast, by Participants
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Component
11.5.5.2. Market Revenue and Forecast, by Application
11.5.5.3. Market Revenue and Forecast, by Participants
12.1. Bayer Healthcare
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Boston Scientific Corporation
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Dexcom, Inc.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Johnson & Johnson
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Koninklijke Philips N.V
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Masimo Corporation
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Medtronic plc
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Omron Corporation
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Samsung Group
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Sanofi
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample